Compare CECO & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CECO | PBH |
|---|---|---|
| Founded | 1966 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 3.3B |
| IPO Year | 2002 | 2004 |
| Metric | CECO | PBH |
|---|---|---|
| Price | $52.40 | $67.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $77.75 | ★ $80.75 |
| AVG Volume (30 Days) | ★ 657.7K | 392.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 280.56 | 2.88 |
| EPS | 1.37 | ★ 2.78 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $24.84 | N/A |
| Revenue Next Year | $11.51 | $2.15 |
| P/E Ratio | $39.64 | ★ $24.57 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $17.57 | $57.25 |
| 52 Week High | $81.72 | $90.04 |
| Indicator | CECO | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 29.67 | 49.12 |
| Support Level | $44.68 | $60.75 |
| Resistance Level | $53.73 | $68.51 |
| Average True Range (ATR) | 4.11 | 1.80 |
| MACD | -2.50 | -0.24 |
| Stochastic Oscillator | 1.78 | 27.93 |
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.